SEER INC. - CLASS A COMMON STOCK

Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook

13 مايو 2025 13:05:00 بحسب Nasdaq GlobeNewswire

Seer to Report First Quarter 2025 Financial Results on May 13, 2025

24 أبريل 2025 13:05:00 بحسب Nasdaq GlobeNewswire

Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook

27 فبراير 2025 13:05:00 بحسب Nasdaq GlobeNewswire

Seer to Participate in the TD Cowen 45th Annual Health Care Conference

21 فبراير 2025 04:00:00 بحسب Nasdaq GlobeNewswire

Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025

20 فبراير 2025 04:00:00 بحسب Nasdaq GlobeNewswire

Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

13 فبراير 2025 13:15:10 بحسب Nasdaq GlobeNewswire

Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference

02 يناير 2025 13:05:00 بحسب Nasdaq GlobeNewswire

Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

21 نوفمبر 2024 13:05:00 بحسب Nasdaq GlobeNewswire

Seer to Participate in Upcoming November Investor Conferences

08 نوفمبر 2024 04:00:08 بحسب Nasdaq GlobeNewswire

Seer Reports Third Quarter 2024 Financial Results

06 نوفمبر 2024 13:05:00 بحسب Nasdaq GlobeNewswire

Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific

06 نوفمبر 2024 13:03:00 بحسب Nasdaq GlobeNewswire

Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024

31 أكتوبر 2024 04:00:00 بحسب Nasdaq GlobeNewswire

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024

21 أكتوبر 2024 04:00:00 بحسب Nasdaq GlobeNewswire

Seer to Report Third Quarter 2024 Financial Results on November 6, 2024

17 أكتوبر 2024 13:05:00 بحسب Nasdaq GlobeNewswire

Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

22 أغسطس 2024 13:05:00 بحسب Nasdaq GlobeNewswire

Seer Appoints Nicolas Roelofs to its Board of Directors

14 أغسطس 2024 13:05:00 بحسب Nasdaq GlobeNewswire

Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference

09 أغسطس 2024 04:00:53 بحسب Nasdaq GlobeNewswire

Seer Reports Second Quarter 2024 Financial Results

08 أغسطس 2024 13:05:00 بحسب Nasdaq GlobeNewswire

Seer to Report Second Quarter 2024 Financial Results on August 8, 2024

18 يوليو 2024 13:03:00 بحسب Nasdaq GlobeNewswire

Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery

11 يونيو 2024 08:11:56 بحسب Nasdaq GlobeNewswire